Bevacizumab and Bleomycin combination for treatment of orbital lymphatico ‐venous malformation recalcitrant to sclerosing therapy alone

Abstract
Orbital lymphatico‐venous malformations (LVMs) represent a spectrum of disease from lymphatic dominant to venous dominant lesions, and present unique, challenging management issues both at the lymphatic and venous dominant ends.

Source: Clinical and Experimental Ophthalmology - January 25, 2018 Category: Opthalmology Authors: Hamzah Mustak, Shoaib Ugradar, Robert Goldberg, Daniel Rootman Tags: Letter to the Editor Source Type: research